Guided Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 15, 2022 at 12:09 am IST
Guided Therapeutics, Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported net loss was USD 1.1 million compared to net income of USD 0.068 million a year ago. Basic loss per share from continuing operations was USD 0.03. Diluted loss per share from continuing operations was USD 0.03.
For the nine months, net loss was USD 2.53 million compared to USD 1.63 million a year ago. Basic loss per share from continuing operations was USD 0.11 compared to USD 0.14 a year ago. Diluted loss per share from continuing operations was USD 0.11 compared to USD 0.14 a year ago.